Growth Metrics

Docebo (DCBO) EBITDA Margin (2019 - 2025)

Historic EBITDA Margin for Docebo (DCBO) over the last 7 years, with Q3 2025 value amounting to 9.77%.

  • Docebo's EBITDA Margin fell 5500.0% to 9.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.83%, marking a year-over-year decrease of 9700.0%. This contributed to the annual value of 10.79% for FY2024, which is 72200.0% up from last year.
  • Docebo's EBITDA Margin amounted to 9.77% in Q3 2025, which was down 5500.0% from 6.99% recorded in Q2 2025.
  • In the past 5 years, Docebo's EBITDA Margin registered a high of 16.24% during Q1 2021, and its lowest value of 5.33% during Q4 2021.
  • Its 5-year average for EBITDA Margin is 7.29%, with a median of 8.31% in 2024.
  • Examining YoY changes over the last 5 years, Docebo's EBITDA Margin showed a top increase of 354500bps in 2021 and a maximum decrease of -25325200bps in 2021.
  • Docebo's EBITDA Margin (Quarter) stood at 5.33% in 2021, then surged by 100bps to 0.01% in 2022, then soared by 193877bps to 12.69% in 2023, then rose by 27bps to 16.07% in 2024, then tumbled by -39bps to 9.77% in 2025.
  • Its EBITDA Margin was 9.77% in Q3 2025, compared to 6.99% in Q2 2025 and 2.56% in Q1 2025.